Cysteamine bitartrate (Mercaptamine bitartrate)是FDA批准的胱氨酸消耗氨基硫醇药物(cystine-depleting aminothiol agent)，通过参与二硫交换减少溶酶体胱氨酸的积累，用于治疗肾病性胱氨酸病。此外，Cysteamine bitartrate还具有抗氧化特性。

27761-19-9

C6H13NO6S

227.24

Mercaptamine bitartrate;Cysteamine bitartrate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years